Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir for COVID-19 survivors. Hsu WH, Tsai YW, Wu JY, Liu TH, et al. J Infect 2023 Feb 9:S0163-4453(23)00076-2. doi: 10.1016/j.jinf.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Hsu WH, Tsai YW, Wu JY, Liu TH, et al. Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir for COVID-19 survivors. J Infect 2023 Feb 9:S0163-4453(23)00076-2. doi: 10.1016/j.jinf.2023.
PMID: 36773894